Behavioural and neurochemical effects of medetomidine, a novel veterinary sedative

https://doi.org/10.1016/0014-2999(88)90260-9Get rights and content

Abstract

The effects of the novel veterinary sedative, medetomidine, were studied in rats. In addition to a dose-dependent sedation, which at high doses (> 100 μg/kg) included loss of the righting reflex and hypothermia, there was a concurrent decrease in the turnover rate of biogenic amines in the brain. Noradrenaline turnover was dose dependently decreased as judged by (i) the decrease in the brain concentration of its metabolite, MHPG-SO4, (ii) a decrease in the ability of α-methyl-p-tyrosine methyl ester to deplete brain noradrenaline stores and (iii) a dose-dependent decrease in the level of unconjugated MHPG in the CSF of freely moving rats. Brain dopamine turnover was also inhibited at higher doses as judged by the α-methyl-p-tyrosine method and by a decrease in the concentration of HVA in the rat brain 4 h after medetomidine. Serotonin turnover as estimated by the ratio of biogenic amine to its metabolite was also significantly depressed. These changes in brain biogenic amine turnover were inhibited by prior or simultaneous administration of α2-adrenoceptor antagonists, either yohimbine or the more specific, novel α2-antagonist, atipamezole.

References (25)

  • N.E. Andén et al.

    Different α-adrenoceptors in the central nervous system mediating biochemical and functional effects of clonidine and receptor blocking agents

    Naunyn-Schmiedeb. Arch. Pharmacol.

    (1976)
  • D. Atlas et al.

    Isolation and purification of clonidine-displacing endogenous brain substance

    European J. Biochem.

    (1984)
  • Cited by (116)

    • Cardiovascular effects of intravenous vatinoxan (MK-467) in medetomidine–tiletamine–zolazepam anaesthetised red deer (Cervus elaphus)

      2020, Veterinary Anaesthesia and Analgesia
      Citation Excerpt :

      A decrease in RT over time was observed in the present study, although no hypothermia (RT <37°C) was detected. Hypothermia can occur in sedated and anaesthetised animals because of impaired thermoregulation and decreased metabolic activity (MacDonald et al. 1988; Grimm & Lamont 2007). In the present study, RT decreased significantly from baseline with both treatments.

    • A novel bioassay for evaluating the efficacy of biocides to inhibit settling and early establishment of marine biofilms

      2014, Marine Pollution Bulletin
      Citation Excerpt :

      TPBP is an organoborane compound mainly used in Japan (Thomas and Langford, 2009) where it has been a common antifouling biocide since 1995 (Mochida et al., 2012). Medetomidine (4-[1-(2,3-dimethylphenyl)ethyl]-1H-imidazole) is traditionally used within veterinary medicine as a sedative agent (Macdonald et al., 1988). Dahlstrom et al. (2000) discovered that medetomidine inhibits barnacle settling at low concentrations and it is now approved as an antifouling biocide in Japan under the trade name Selektope® (Ohlauson and Blanck, 2014).

    • Developmental and behavioral effects of medetomidine following in ovo injection in chicks

      2012, Neurotoxicology and Teratology
      Citation Excerpt :

      Medetomidine is usually combined with ketamine to produce general anesthesia in dogs, cats and avian species (Short, 1992; Cornick-Seahorn, 2001; Sinclair, 2003; Ansah, 2004; Murrell and Hellebrekers, 2005). The pharmacological effects of medetomidine are mediated via activation of alpha-2 adrenoceptors resulting in reduced catecholamine release and turnover (MacDonald et al., 1988, 1989; Virtanen, 1989; Virtanen et al., 1989). The side effects of medetomidine in animals are characterized by bradycardia, hypoventilation, urination, salivation, hypothermia and hypotension (MacDonald et al., 1989; Mohammad et al., 1991; Short, 1992; Mohammad et al., 1993b, 1995; Cornick-Seahorn, 2001; Sinclair, 2003; Ansah, 2004).

    • Sedative and cardiorespiratory effects of dexmedetomidine and buprenorphine administered to cats via oral transmucosal or intramuscular routes

      2010, Veterinary Anaesthesia and Analgesia
      Citation Excerpt :

      After medication, heart rate decreased significantly in both groups. The decrease might have been due to two known dexmedetomidine‐induced phenomena: an increase in arterial blood pressure inducing a baroreceptor‐mediated increase in vagal outflow causing bradycardia, or a decrease in sympathetic tone due to dexmedetomidine‐mediated decrease in norepinephrine release in the CNS (MacDonald et al. 1988; Ansah et al. 1998). It is possible that we did not observe an increase in SAP after dexmedetomidine in our cats because SAP was already increased by handling and environmental factors before the dexmedetomidine was given.

    View all citing articles on Scopus
    View full text